ITF Therapeutics

ITF Therapeutics is guided by the voices of the communities it serves. The company values personal stories and experiences, playing a unique role in helping to understand the impact of rare diseases on patients and caregivers. The voice of patient communities also helps the company understand the most effective ways to collaborate with and support patients, families, and healthcare professionals. ITF Therapeutics is honored to collaborate with leaders in advocacy, research, and patient care, striving to create a brighter future for patients with rare diseases such as Duchenne Muscular Dystrophy (DMD). As a new division of Italfarmaco, ITF Therapeutics focuses on the development and commercialization of treatments for rare diseases, including DMD.